✦ LIBER ✦

Quetiapine for the treatment of drug-induced psychosis in Parkinson's disease

✍ Scribed by Hubert H. Fernandez; Joseph H. Friedman; Carol Jacques; Michael Rosenfeld

Publisher: John Wiley and Sons
Year: 1999
Tongue: English
Weight: 25 KB
Volume: 14
Category: Article
ISSN: 0885-3185
DOI: 10.1002/1531-8257(199905)14:3<484::aid-mds1016>3.0.co;2-b

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clozapine replacement by quetiapine for

Clozapine replacement by quetiapine for the treatment of drug-induced psychosis in Parkinson's disease

✍ Hubert H. Fernandez; Margaret C. Lannon; Joseph H. Friedman; Bruce P. Abbott 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 110 KB 👁 1 views

Cases of delayed or acute posttraumatic, therapy-resistant tremor have been previously described. [1][2][3][4] The onset is usually delayed (weeks to months/years), but they may also begin rapidly (within hours). Careful neuroradiologic examination may reveal small lesions, often in the deep brain a

Atypical antipsychotics in the treatment

Atypical antipsychotics in the treatment of drug-induced psychosis in Parkinson's disease

✍ Joseph H. Friedman; Stewart A. Factor 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB 👁 2 views

Risperidone in the treatment of dopamine

Risperidone in the treatment of dopamine-induced psychosis in Parkinson's disease: An open pilot trial

✍ Erich Mohr; Tilak Mendis; Kathleen Hildebrand; Peter Paul De Deyn 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 78 KB 👁 2 views

## Purpose: To evaluate the safety and efficacy of risperidone in patients with parkinson's disease (pd) who are experiencing significant dopamine-induced psychosis. ## Patients and methods: Seventeen patients (median age, 72 yrs) participated in this 12-week, open pilot study receiving 0.5 to 3

Clozapine for the treatment of drug-indu

Clozapine for the treatment of drug-induced psychosis in Parkinson's disease: Results of the 12 week open label extension in the PSYCLOPS trial

✍ Stewart A. Factor; Joseph H. Friedman; Margaret C. Lannon; David Oakes; Keith Bo 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 33 KB 👁 2 views

Viral vectors in the treatment of Parkin

Viral vectors in the treatment of Parkinson's disease

✍ David S. Latchman; Robert S. Coffin 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 88 KB 👁 2 views

s disease is an obvious target for the development of gene therapy procedures which could involve both the delivery of the gene encoding tyrosine hydroxylase to boost dopamine production or the delivery of genes encoding neurotrophic factors such as GDNF to promote the survival of dopaminergic neuro

Drug selection and timing of initiation

Drug selection and timing of initiation of treatment in early Parkinson's disease

✍ Anthony H. V. Schapira; C. Warren Olanow 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 141 KB 👁 1 views